ARTV

ARTIVA BIOTHERAPEUTICS INC

• TipRanks·03/12 13:20

  Artiva Biotherapeutics, Inc. (ARTV) Receives a Buy from Jefferies

• TipRanks·03/11 13:30

  Analysts Offer Insights on Healthcare Companies: Artiva Biotherapeutics, Inc. (ARTV) and Edgewise Therapeutics (EWTX)

• TipRanks·03/11 12:20

  Analysts Offer Insights on Healthcare Companies: Artiva Biotherapeutics, Inc. (ARTV) and Clinigence Holdings (NUTX)

• Dow Jones·03/11 10:59

  Artiva Biotherapeutics Price Target Maintained With a $18.00/Share by Needham

• TipRanks·03/11 10:55

  Artiva: Sufficient Cash Runway to 2027 Supports Buy Rating Ahead of Key 2026 RA Efficacy Readouts

• Benzinga·03/11 10:48

  Needham Reiterates Buy on Artiva Biotherapeutics, Maintains $18 Price Target

• TipRanks·03/11 10:35

  Artiva: De-Risking RA Opportunity With AlloNK and Fast-Track Path Supports Buy Rating

• NASDAQ·03/11 07:31

  Artiva Posts Wider FY25 Loss, Prepares For Key AlloNK Data In Refractory RA

• TipRanks·03/10 23:10

  Analysts Are Bullish on These Healthcare Stocks: Telix Pharmaceuticals (TLPPF), Artiva Biotherapeutics, Inc. (ARTV)

• Seeking Alpha·03/10 20:21

  Artiva Biotherapeutics GAAP EPS of -$3.43

• Dow Jones·03/10 20:20

  *Artiva Biotherapeutics FY25 Loss $83.9M >ARTV

• Dow Jones·03/10 20:20

  *Artiva Biotherapeutics FY25 Loss/Shr $3.43 >ARTV

• Dow Jones·03/10 20:20

  *Artiva Biotherapeutics: Initial Clinical Response Data for AlloNK in Refractory Rheumatoid Arthritis Expected in 1H >ARTV

• Dow Jones·03/10 20:20

  *Artiva Biotherapeutics: FDA Interaction to Discuss Potential Pivotal Trial Design for AlloNK Expected in 1H >ARTV

• Dow Jones·03/10 20:14

  *Artiva Biotherapeutics Sees Funding Ops Into 2Q of 2027 >ARTV